Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan (Q38760536)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 May 2017

Language	Label	Description	Also known as
English	Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan	scientific article published on 26 May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

author name string

Shota Saito

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Motoi Azumi

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Yusuke Muneoka

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Katsuhiko Nishino

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Takashi Ishikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Yuichi Sato

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Shuji Terai

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Kouhei Akazawa

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

The European Journal of Health Economics

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cost of illness of the stomach cancer in Japan - a time trend and future projections

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Helicobacter pylori infection and the development of gastric cancer

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

The ABC Method and Gastric Cancer: Evidence From Prospective Studies

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivors after endoscopic resection of early gastric cancer

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Strategy for Eliminating Gastric Cancer in Japan

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Sensitivity of endoscopic screening for gastric cancer by the incidence method

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Usefulness of serum pepsinogen levels as a screening test for atrophic gastritis and gastric cancer

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Population screening and treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?

1 reference

https://api.crossref.org/works/10.1007/S10198-017-0901-Y

21 January 2018

Endoscopic screening for gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28550494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence country.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28550494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Illustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/28550494

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10198-017-0901-Y

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38760536&oldid=2202049670"